Development pharmacovigilance and risk management plan

Plan to conduct the detection, assessment, understanding, reporting and prevention of AEs of medicinal products during clinical trials.


Take advantage of the knowledge and best practices gained from more than 20 years of research, innovation and development for the health and life sciences sectors.